MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
30.22
-0.09 (-0.30%)
Apr 29, 2026, 12:43 PM EDT - Market open
MapLight Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,330 | 767 | - | - | - |
| Enterprise Value | 1,035 | 1,053 | - | - | - |
| Last Close Price | 30.31 | 17.57 | - | - | - |
| PB Ratio | 2.91 | 1.67 | - | - | - |
| P/TBV Ratio | 2.91 | 1.67 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.06 | 0.08 | 0.30 |
| Net Debt / Equity Ratio | -0.65 | -0.65 | -0.89 | -1.04 | -1.02 |
| Net Debt / EBITDA Ratio | 1.78 | 1.78 | 1.24 | 1.30 | 0.70 |
| Net Debt / FCF Ratio | 2.16 | 2.16 | 1.28 | 1.41 | 0.78 |
| Quick Ratio | 18.80 | 18.80 | 6.83 | 5.43 | 2.20 |
| Current Ratio | 20.01 | 20.01 | 7.20 | 5.69 | 2.54 |
| Return on Equity (ROE) | -56.19% | -56.19% | -83.21% | -120.91% | - |
| Return on Assets (ROA) | -34.29% | -34.29% | -45.41% | -54.74% | - |
| Return on Capital Employed (ROCE) | -36.50% | -36.50% | -68.60% | -74.70% | -116.60% |
| Earnings Yield | -12.08% | -21.02% | - | - | - |
| FCF Yield | -10.39% | -18.08% | - | - | - |
| Buyback Yield / Dilution | -1079.16% | -1079.16% | -11.60% | -18.43% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.